The feasibility and clinical effects of dendritic cell-based immunotherapy targeting synthesized peptides for recurrent ovarian cancer

BACKGROUND: Despite the increased rate of complete response to initial chemotherapy, most patients with advanced ovarian cancer relapse and succumb to progressive disease. Dendritic cell (DC)-based immunotherapy has been developed as a novel strategy for generating antitumor immunity as part of canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Masanori, Chiba, Asako, Izawa, Hiromi, Yanagida, Eri, Okamoto, Masato, Shimodaira, Shigetaka, Yonemitsu, Yoshikazu, Shibamoto, Yuta, Suzuki, Noboru, Nagaya, Masaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108140/
https://www.ncbi.nlm.nih.gov/pubmed/25298213
http://dx.doi.org/10.1186/1757-2215-7-48

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108140/
https://www.ncbi.nlm.nih.gov/pubmed/25298213
http://dx.doi.org/10.1186/1757-2215-7-48

Ejemplares similares